. CSF Biomarkers for Secondary Prevention Trials: Why Markers of Amyloid Deposition and Neurodegeneration Are Both Important. Arch Neurol. 2012 Apr 23; PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

News

  1. Biomarker Duo Signals Mental Decline